Skip to content
Dose Brief
Menu
No. 10 on the board · Grade B+

Vytora Health review

A rare accredited desk that pairs brand-name access with fair mid-market compounded pricing across all 50 states.

Visit Vytora Health Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
$150/mo
Tirzepatide
$200/mo
Coverage
All 50 states
Brand-name
Yes
On the trackerStableprice stable$150 sema / $200 tirz nationwide; LegitScript-certified with brand-name access.

The scorecard

Vytora Health scored on our six Brief Score factors. See the methodology.

Price Stability85/100
Supply Reliability87/100
Transparency88/100
Access Breadth90/100
Clinical Oversight88/100
Track Record82/100

What we like

  • Brand-name access alongside competitively priced compounded options
  • LegitScript-certified, all 50 states
  • Clean $150/$200 pricing disclosed up front

The caveats

  • Short public track record
  • No oral route

The brief

Best for: Readers who want a LegitScript-certified desk that can also route to brand-name GLP-1s — without paying a premium for it. A rare accredited desk that pairs brand-name access with fair mid-market compounded pricing across all 50 states.

Ranked #10 of 25 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 24 other providers we've reviewed, in our overall ranking order.

Pricing, states and verification reflect Vytora Health's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on Vytora Health's site. Not medical advice; see our disclosure.

← Back to all rankings